Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Increased nitric oxide (NO) production may contribute to the pathological changes featuring in some inflammatory diseases, but the role of NO in chronic viral hepatitis is still unknown. We compared the inducible NO synthase (NOS2) expression in the liver of patients with chronic viral hepatitis with that of both nonviral liver disease and histologically normal liver. NOS2 expression was assessed by immunohistochemical and in situ hybridization studies of liver biopsy sections. An intense hepatocellular NOS2 reactivity was detected in chronic viral hepatitis, whereas it was weakly or not observed in nonviral liver disease or normal liver, respectively. In addition, we determined whether the hepatitis B virus (HBV) might regulate the synthesis of this enzyme. NOS2 mRNA and protein levels as well as enzyme activity were assessed in cytokine-stimulated HBV-transfected and untransfected hepatoma cells. Transfection with either HBV genome or HBV X gene resulted in induction of NOS2 mRNA expression, and the maximal induction of this transcript and NO production was observed in cytokine-stimulated HBV-transfected cells. These results indicate that hepatotropic viral infections are able to upregulate the NOS2 gene expression in human hepatocytes, suggesting that NO may mediate important pathogenic events in the course of chronic viral hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678 · cited 1×
“NO is an important effector molecule involved in a wide variety of physiological processes, such as neurotransmission, vasodilation, and cytotoxicity (44).”
BackgroundStimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
Nussler, A. K., Di Silvio, M., Billiar, T. R., Hoffman, R. A., Geller, D. A., Selby, R., Madariaga, J., & Simmons, R. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.1.261 · Cited by 420 · cited 1×
“The inducible isoform (NOS2) can be expressed de novo by many cell types, including macrophages (6) and hepatocytes (7), after induction with bacterial endotoxin and proinflammatory cytokines (8, 9), thus producing large quantities of NO.”
Background
Cited by
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Inducible nitric oxide synthase: Regulation, structure, and inhibition
Cinelli, M. A., Do, H. T., Miley, G. P., & Silverman, R. B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21599 · Cited by 889
Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
“IL-6 immunohistochemistry was semiquantitatively evaluated in a blinded fashion regarding any of the clinical and laboratory characteristics of the patients using a previously described 4-point scoring system (0, no staining; 1, positive staining in less than 30% of cells per high-power field; 2, positive staining in…”
MethodREGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
Aitken, A. E., Richardson, T. A., & Morgan, E. T. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141059 · Cited by 448
Oxidative stress in viral and alcoholic hepatitis
Loguercio, C., & Federico, A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01167-x · Cited by 424
FU, S., RAMANUJAM, K., WONG, A., FANTRY, G., DRACHENBERG, C., JAMES, S., MELTZER, S., & WILSON, K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70496-8 · Cited by 408
Nitric oxide and virus infection
Akaike, T., & Maeda, H. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00142.x · Cited by 365
Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O., & Bartenschlager, R. (2002) · Hepatology · doi:10.1053/jhep.2002.31770 · Cited by 314
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis
Jaiswal, M., LaRusso, N. F., & Gores, G. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g626 · Cited by 278
Garcia-Monzón, C., Martín-Pérez, E., Iacono, O. L., Fernández-Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., & Moreno-Otero, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80301-3 · Cited by 265
Self-citationRole of free radicals in viral pathogenesis and mutation
Akaike, T. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.303 · Cited by 207
Sanders, S. P., Siekierski, E. S., Richards, S. M., Porter, J. D., Imani, F., & Proud, D. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112028 · Cited by 72
S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver
Leung, J., Wei, W., & Liu, L. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt031 · Cited by 12
“that predispose to HCC [6-9].”
Metadata
- Authors
- Majano, P. L., García-Monzón, C., López-Cabrera, M., Lara-Pezzi, E., Fernández-Ruiz, E., García-Iglesias, C., Borque, M. J., & Moreno-Otero, R.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-04-01
- Volume
- 101
- Issue
- 7
- Pages
- 1343-1352
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2024897106
- Cited by
- 151
- References
- 2
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.